-
Events: Invicro at WMIC 2016
BOSTON, MA (August 26, 2016) – Read more about our attendance at WMIC, including presentations by our team. SEE MORE
-
Webinar: High-Throughput Three-Dimensional Tissue Imaging in the Bright-Field, Fluorescence and Nuclear Regimes | June 8 | 11am EST
In this talk, Jack Hoppin, Invicro co-founder, focuses on the strengths and limitations of these emerging translational tomographic techniques and technologies and evaluates their application as imaging biomarker tools.
Get access to the recorded webinar here.
-
Events: Invicro at SNMMI 2016
BOSTON, MA (June 10, 2016) – Read more about our attendance at SNMMI, including presentations by our team. SEE MORE
-
News: Invicro Featured in WMIS Video Contest
BOSTON, MA (June 8, 2016) – Invicro is the proud winner of the 2015 WMIS “This is Our Lab” Contest. Winners were featured in a video to showcase their work, and the final product has been released on the WMIS website. SEE MORE
-
Event: Invicro Hosts Translational Imaging Symposium in Boston
BOSTON, MA (May 12, 2016) Leaders in translational molecular imaging will be presenting on the latest innovations and emerging global trends in the field. We look forward to hosting another event which will provide a forum for thought-leaders in translational imaging to share insights into the latest advancements in the field. SEE MORE
-
News: AXT Brings Invicro’s Preclinical Medical Imaging Products to Australia
BOSTON, MA (April 5, 2016) AXT has recently bolstered their preclinical and translational imaging products portfolio with the addition of Invicro’s innovative software platforms. SEE MORE
-
News: Invicro Acquires Molecular NeuroImaging (MNI) to Establish Full Spectrum Translational Imaging Capabilities
BOSTON, MA (February 25, 2016) – Invicro, LLC, and Molecular NeuroImaging, LLC, both leading providers of imaging service solutions and analysis software for research and drug development, announced they will merge all activities to provide the most comprehensive set of imaging services across the spectrum of drug development. Invicro has acquired MNI and MNI will operate as a division of Invicro. SEE MORE
-
News: Invicro UK launches MIAKAT™ – software package for the quantitative analysis of PET neuroimaging data — Invicro
-
News: Invicro UK drives innovation in imaging – announcing winners of its IMPETus 2015 Pilot Grants — Invicro
-
News: PET imaging enhanced immuno-oncology drug development — Invicro
-
News: Magnetic resonance imaging reveals the complementary effects of decongestant and Breathe Right Nasal Strips on internal nasal anatomy — Invicro
-
News: Possible cognitive impairments found in some HIV-positive patients despite effective treatment — Invicro
-
News: Update on MIAKAT™ — Invicro
-
News: Introduction to i-Biomarkers and preclinical sciences — Invicro
-
, now physically on the ground — Invicro”]SEE MORE
-
News: Yale team makes breakthrough that will transform the way we study CNS diseases — Invicro
-
News: Events: Invicro UK delivers 11 presentations at NRM2016 — Invicro
-
News: Invicro UK, in collaboration with Roche and Imperial, characterise radio-tracer for imaging addiction pathways — Invicro
-
News: Invicro UK is proud to be involved with the DPUK — Invicro
-
News: Invicro UK plays central role in world’s most in-depth study to detect Alzheimer’s and identify early signs of the disease — Invicro
-
News: PET/MRI scanner installed at Invicro UK — Invicro
-
News: Hippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple Sclerosis – A PET/MRI Study — Invicro
-
News: Gut Hormones in Addiction (GHADD) Study at Hammersmith Hospital — Invicro
-
News: New Imaging biomarkers (ligands) available at Invicro UK
-
News: Invicro UK among the Scrip Awards' finalists — Invicro
-
News: Invicro UK strives to image Neurodegenerative Disease pathways to improve drug development — Invicro
-
News: Imaging+ – advanced translational imaging for CNS Drug Development — Invicro
-
News: Does Alzheimer's Disease pathology spread across the brain? Invicro UK answers this for b-amyloid — Invicro
-
News: Gaming Technology Helps Dementia Imaging — Invicro
-
Events: Invicro UK at BRAIN 2015 — Invicro
-
News: PET Rocks! — Invicro
-
News: Invicro UK in September's Nature Biopharma Dealmakers — Invicro
-
News: Applications for the 4th IMPETus Pilot Grants Programme now open! — Invicro
-
News: Improved experience for Dementia sufferers during imaging – Invicro UK’s clinical team complete Alzheimer’s Society expert training program — Invicro
-
News: It all starts with a thought! — Invicro
-
News: Learn new things everyday! — Invicro
-
News: A week dedicated to Nuclear Medicine & Molecular Imaging — Invicro
-
News: Yale invasion continues at Invicro UK — Invicro
-
Events: Invicro UK at EANM'15 in Hamburg — Invicro
-
News: Breakthrough in development of treatment for schizophrenia — Invicro
-
News: Nature Publication's BioPharma Dealmakers has a feature on Invicro UK
-
News: Featured Article in PMB — Invicro
-
News: Invicro UK and Imperial College collaborate on state-of-the-art imaging for dementia drug research — Invicro
-
News: Invicro UK collaborates with Teva and UCL on unique Brain Imaging Study aimed at unlocking A New Approach in Neurodegenerative Disease — Invicro
-
News: What if we could really read the brain? — Invicro
-
News: Invicro UK opens call for IMPETUS PET pilot awards — Invicro
-
News: Kevin Cox to Chair Session at Genesis 2014 Conference — Invicro
-
News: Invicro UK creates its first imaging biomarker for CNS research — Invicro
-
Events: Invicro Hosts Software User Meeting
BOSTON, MA (September 29, 2015) – Invicro’s first Software User Meeting was held on September 23rd at Boston’s District Hall, and was attended by more than 70 Invicro software users (in person and remote). SEE MORE
-
Publications: Invicro Scientific Presentations at WMIC 2015
Abstracts:Cryoflourescence Tomography (CFT) is an Ex Vivo Tool to Study Anatomy, Physiology, and Drug or Tracer Distribution in Brain and Other Organs SEE MORE
-
Events: Invicro at the 2015 World Molecular Imaging Congress
BOSTON, MA (September 29, 2015) – Five Invicro teammates were pleased to attend September’s World Molecular Imaging Congress and continued to focus on fostering industry and academia relations… SEE MORE
-
News: Invicro Expands Preclinical Histology Service Capabilities with the Opening of Invicro Seattle
Invicro expands 2D/3D histology imaging and analysis services for research and drug development
BOSTON, MA (March 20, 2015) – Invicro announced today its expansion of histology capabilities with the acquisition of a Seattle-based histology team and the opening of Invicro Seattle. SEE MORE
-
Software Release: Introducing VivoQuant® 2.0
BOSTON, MA (February 25, 2015) – Invicro is excited to announce the release of VivoQuant® 2.0! Based on the valuable feedback of our customers, we have improved VivoQuant®’s user experience, making it more intuitive and even easier to interact with. FUJIFILM VisualSonics Inc., a world leader in real-time, in vivo, high-resolution micro-imaging systems designed specifically for pre-clinical research and a subsidiary of FUJIFILM SonoSite, Inc, is pleased to announce a new and exclusive partnership with Invicro, LLC, and the development of the VisualSonics iPACS® Imaging Study Management System. SEE MORE
-
News: Invicro Expands Translational Imaging Capacity with Cyclotron Facility
BOSTON, MA (May 26, 2015) – Born out of a strategic partnership between Invicro, MPI Research, and 3D Imaging, the TIC features the only industry-owned and -operated cyclotron facility with contiguous vivarium facilities in the world. SEE MORE
-
Events: Governor Patrick Visits Invicro, Celebrates New Collaboration Stemming From Israel Trade Mission
BOSTON, MA (December 1, 2014) – Last week Governor Deval Patrick visited Invicro, a fast-growing Boston life sciences firm, to join in announcing the company’s expanded development agreement with Israel-based Aspect Imaging. SEE MORE
-
Events: Invicro to Host Translational Imaging Symposium Featuring Leading Imaging Scientists in Drug Development and Research
-
News: Invicro’s Three Year Growth Rate of 687% Earns Second-Consecutive Appearance on Inc. Magazine’s 500 | 5000 list
BOSTON, MA (September 2, 2014) – Invicro recognized as one of the top 700 fastest growing private companies in the United States and No. 20 in Boston metro area SEE MORE
-
News: Jack Hoppin, Ph.D., Co-Founder and Managing Director of Invicro, LLC, joins the Board of Trustees of the WMIS
BOSTON, MA (August 26, 2014) – Invicro is pleased to announce the selection of co-founder and Managing Director Jack Hoppin, Ph.D., to the Board of Trustees of the World Molecular Imaging Society (WMIS). SEE MORE
-
News: Translational Imaging Center to Speed Drug Development, Lower Costs
Mattawan, MI (February 4, 2014) – MPI Research, Invicro, and 3D Imaging today formally announced the name of their new advanced imaging center being built at the MPI Research headquarters in Mattawan, Michigan. SEE MORE
-
News: INVICRO named the 327th fastest growing company and 20th in the top 100 Health Companies
Boston, MA (August 22, 2013) – Invicro, LLC, a leading imaging services and software organization, has been named the 327th fastest growing company in the USA according to the Inc. Magazine 5000 list released this week. SEE MORE
-
News: INVICRO, MPI Research, and 3D Imaging Announce Strategic Partnership
BOSTON, MA (June 14, 2013)– Invicro, an industry-leading imaging software and contract research organization, is pleased to announce a strategic partnership with MPI Research and 3D Imaging to unite world-class molecular imaging, radiochemistry, and informatics to accelerate drug discovery and development. SEE MORE
Contact the Author:
Amanda Harrell | T. +1 215-644-3409 | E. aharrell@invicro.com